Antimicrobial Agent Use

Treatment Pathways

Our Treatment Pathways are based on national guidelines and consensus statements, expert opinions from the Infectious Diseases team (pharmacy and medicine), and microbiology data from the microbiology laboratory.

Aminoglycosides

• Aminoglycoside High Dose Once Daily (HDOD) and Monitoring in Adult Patients

Antimicrobials for Surgery

•  Surgical Decolonization and Prophylaxis

Duration of Therapy

• Antimicrobial Duration of Therapy

Febrile Neutropenia

• Febrile Neutropenia

Guidelines for Restricted  Antimicrobials

• Guidelines for Restricted Antimicrobials 

For Antibiotics

• Ceftaroline
• Ceftazidime
• Ceftolozane
• Colistin 
• Dalbavancin
• Daptomycin
• Delafloxacin (Baxdela)
• Ertapenem
• Fidaxomicin
• Fosfomycin
• Linezolid
• Meropenem and Vaborbactam (Vabomere)
• Oritavancin
• Polymyxin B
• Colistin (Polymyxin E or Colistimethate)
• Tedizolid
• Tigecycline

For Antifungals

• Liposomal Amphotericin B
• Caspofungin
• Isavuconazonium sulfate
• Voriconazole

Monoclonal Antibody

• Bezlotoxumab (Zinplava)

Infection Control

• Infection Control

IV to PO Step-Down

• IV to PO Step-Down Guidelines

PK Calculations

• Pharmacokinetic Calculations

Renal Dosage Adjustments

• Antimicrobial Dosing Guidelines for Adult Patients Based on Renal Function

Vancomycin

• Guidelines for Vancomycin Dosing and Determination of Trough Levels in Adult Patients